Abstract: This invention relates to a composition for use in the treatment of iodine deficiency diseases such as fibrocystic dysplasia of the breast, breast cancer, endometriosis and premenstrual syndrome. The composition may also be used for the prophylaxis of breast cancer. More particularly, this invention relates to a composition for the treatment of iodine deficiency diseases, the composition comprising a solution of elemental iodine (I.sub.2) which may also be referred to as metallic iodine or iodine metal. The elemental iodine is soluble in water which leaves it thermodynamically free. The term "aqueous iodine" may also be used to refer to such an aqueous solution.

Abstract: A method of preparing a stable, low K-value, water-soluble polyvinylpyrrolidone-iodine product in the form of a uniform, free-flowing powder which comprises mixing a given amount of water-soluble polyvinylpyrrolidone polymer having a K-value of about 10-20 and about 10-20% by wt. iodine, and about 0.1-0.5% isopropanol, intimately mixing the reactants at room temperature for a sufficient period of time for the iodine to disappear as a separate phase, and then heating the reaction powders while mixing at about 65.degree.-85.degree. C. for a reaction period of at least about 18 hours.

Abstract: There is disclosed a composition useful for medicated treatment of hooves of live animals. The composition comprises a major portion of a carrier and hoof penetrant, a minor amount of a filler comprising chiefly polyolefin fibers, and an oil-in-water emulsifier to form a staple composition. The composition can include optional quantities of a medicinal compound. A specific example of the compound comprises approximately 12 weight percent of chopped fibers of a polyolefin such as polyethylene or polypropylene, about 69 percent of a carrier comprising pine tar, paraffin wax and coconut oil, and an oil-in-water emulsifier such as an aliphatic alcohol or alkyl glucose fatty acid ester. Preferably, the composition also includes a medicinal compound such as alcohol, iodine or a soluble iodide. The method comprises packing the hooves of live animals such as horses with the composition.

Abstract: A composition for a topically applied therapeutic cream or ointment having effective activity against one or a combination of sources of viral, bacterial, yeast and fungus infections characterized by the ability to penetrate beneath the epidermal layer of the skin. The composition includes a water soluble active component which is formulated with a water soluble organic solid base and a water soluble surfactant to form an aqueous solution having a gel-like consistency. A preferred active ingredient is a povidone-iodine complex. A preferred carrier is hydroxyethylcellulose.

Abstract: Povidone-Iodine (PVP-I) solutions stable according to U.S.P. standards and a method for preparing the same are disclosed. The PVP-I solution includes a microbicidal effective amount of available iodine and an alkalinizing agent in an effective amount to maintain the stability of the solution for a desired shelf-life of the solution when said solution is stored in a substantially nonpermeable container, the solution being non-buffered. In preferred embodiments, the iodophor solution is a microbicidal PVP-I solution for ophthalmic use.

Abstract: An orally acceptable nutrient and mineral supplement for reducing hair loss wherein the composition contains divalent iron and pantothenic acid in a weight to weight ratio of approximately 1-3 and racemic d, 1-methionine. A particularly preferred composition contains 11.25 mg. of divalent iron as ferrous fumarate and 35 mg. of pantothenic acid as calcium pantothenate and 200 mg. of d,1-methionine.

Abstract: A germicidal iodophor composition is disclosed having improved long term stability, by controlling the pH of the composition and supplementing the elemental iodine with a source of periodate. The present invention comprises an iodophor composition comprising periodate and having a pH of about 4.5 or below. Processes for making the iodophors, as well as methods for killing bacteria on a substrate using these germicidal iodophor compositions are also disclosed.

Abstract: Polycondensation silicone elastomer dosage forms adapted for the continuous and controlled release of iodine values, notably to domestic water supplies for the treatment of the various disease states attributed to iodine deficiency, are shaped from (A) at least one diorganopolysiloxane oil bearing at least two condensable or hydrolyzable groups, or a single hydroxyl group, at each end of the polymer chain; (B) a therapeutically effective amount of at least one water soluble, nontoxic, organic and/or inorganic iodine compound which is in solid or liquid state at ambient temperature and which does not inhibit curing of the composition into an elastomer; (C) a catalytically effective amount of a polycondensation catalyst; and optionally, (D) a silane containing at least three condensable or hydrolyzable groups.

Abstract: A gelling composition for an aqueous liquid includes ungellated starch which has been reacted with a silane coupling agent. In preferred compositions, the starch is a starch-polyacrylate graft copolymer and the composition includes a polyacrylate gelling agent. A disinfectant may be added to the composition for compositions intended for use with medical waste.

Abstract: A sustained and controlled release form of iodine is achieved by a complex of polyvinyl alcohol and the iodine characterized by a low water solubility. The polyvinyl alcohol may be reacted to form hydroxylated polyvinyl acetal sponge and the sponge is topically applied as an antimicrobial agent which releases controlled amounts of iodine sufficient to kill germ cells with minimal toxicity to surrounding tissue.

Abstract: An antimicrobial composition for the treatment of non-oral and non-periodontal human disorders due to infectious microorganisms susceptible to antimicrobial treatment and wherein the composition is an aqueous or aqueous alcoholic solution of povidone iodine complex to which nascent oxygen is supplied and the resulting admixture being freshly applied to the said disorders.

Abstract: There is disclosed an antiseptic polish for covering highly touched surfaces which contain a solution comprising Povidone-Iodine of approximately 7.5 to 10 percent by volume dispersed in a liquid polish.

Abstract: A water soluble complex of polyvinylpyrrolidone, hydrogen chloride and iodine, and a process for making the same, is provided herein.

Abstract: A stable concentrated iodophor composition is useful in aqueous solution for control of microorganisms in the therapeutic and prophylactic culture of aquatic animals such as fish, reptiles, and amphibians. It is effective against bacteria, fungi, viruses, algae and the like in very dilute solution while being non-toxic to higher animals. Its biocidal action is due in large measure to the action of iodine that is slowly released into the water. The solution has low-foaming properties to enable its use with water systems having moving water in fountains, filters and bubble aerators. The composition includes phosphoric acid, ethylene glycol monobutyl ether, and two iodophors, a first iodophor formed by mixing iodomethane with a quaternary ammonium surfactant and a second iodophor formed by heating iodine with either an alkyl phenoxyl polyether alcohol or oleic acid sulfonate.

Abstract: An emulsion containing a substantially water resistant film-forming copolymer phase and iodine is claimed. The polymer-in-water emulsion forms a film that is a substantially fluid resistant, low tack, flexible film which adheres to skin and releases iodine to skin. The addition of iodate to emulsions having such a film-forming copolymer phase and iodine further enhances stability of the emulsion.

Abstract: A pharmaceutical iodophor preparation having predictable microbicidal effectiveness and long duration of action comprising polyvinylpyrrolidone-iodine (PVPI), free iodine, a source of iodide ions and a source of iodate ions, the preparation having a ratio of available (titratable) iodine to iodide between 2:1 and 10:1, a pH between 5 and 6 and a free iodine concentration between 2 and 20 ppm, wherein the amount of iodate ion in the preparation is sufficient to maintain the free iodine concentration between 2 and 20 ppm for at least 12 months at 20.degree. C.

Abstract: A solid iodophor composition contains a water-soluble iodophor, especially povidone iodine, and at least one of a urea and a sugar alcohol, especially mannitol, sorbitol or xylitol. The composition may also contain a sugar such as sucrose or lactose.The advantage claimed in the ready solublility of the composition in water. This would allow the supply of iodophors in solid, rather than liquid, form.

Abstract: Iodine-containing germicidal preparations are provided with assured control of the content of equilibrium iodine in aqueous solution to be between 1 and 20 ppm, preferably 2-15 ppm so as to provide predetermined germicidal activity. The invention further comprises the determination of the content of equilibrium iodine in an aqueous iodophor solution by subjecting such solution to several extractions with different amounts of a water immiscible solvent for iodine, determining the concentrations of the equilibrium iodine in each of the amounts of the water immiscible solvent and extrapolating the concentration to a theoretical zero value which is a measure of the equilibrium iodine in the aqueous iodophor solution. The invention further comprises improved germicidal iodophor compositions comprising an iodophor, citric acid and iodate.

Abstract: A process for preparing a dermatological lotion comprises sequentially adding 160 to 240 g. salicylic acid, 160 to 240 g. alum powder and 45 to 55 tincture of iodine to 800 to 1200 ml. ethyl alcohol to provide a mixture, homogenizing the mixture, and then maintaining the homogenized mixture quiescent for at least one week.

Abstract: A germicidal iodine-containing composition includes iodine, an iodophor, cupric ions and nitrite ions in an aqueous base. Iodide ions which form in the composition during radiation sterilization or prolonged shelf life are oxidized back to iodine by the cupric ions in a Ph dependent reaction which consumes hydrogen ions formed concurrently with the iodide ions. Cuprous ions formed during the oxidation are spontaneously cycled back to cupric ions by traces of air present in the composition. The composition may include nitrite ions to augment the conversion of cuprous ions back to the cupric form.

Abstract: A sustained release device which comprises a source of at least one trace chemical element incorporated in a cement and releasable therefrom on contact with an aqueous medium.The trace chemical element is exemplified by selenium, cobalt and iodine and the cement is exemplified by a phosphate cement.

Abstract: Polyaddition silicone elastomer dosage forms adapted for the continuous and controlled release of iodine values, notably to domestic water supplies for the treatment of the various disease states attributed to iodine deficiency, are shaped from (A) at least one organopolysiloxane containing at least two vinyl groups bonded to silicon per molecule; (B) at least one organopolysiloxane containing at least three hydrogen atoms bonded to silicon; (C) a catalytically effective amount of a platinum group metal compound; and (D) a therapeutically effective amount of at least one water soluble, nontoxic, organic and/or inorganic iodine compound which is in solid or liquid state at ambient temperature and which does not inhibit the catalytic activity of the platinum group metal compound (C).

Abstract: The microbicidal effectiveness of pharmaceutical iodophor preparations comprising an organic substance which reacts with iodine to form a complex thereof, such as polyvinylpyrrolidone, iodine bound thereto in complex form, free iodine, and iodide ions, is assured by controlling the ratio of total iodine (complex bound iodine and free iodine) to iodide ions at between 2:1 and 10:1, this ratio being adjusted without chemical oxidizing agents such as iodate ions by anodic oxidation of a solution of the iodophor preparation and iodide ions. The resulting preparation can be free of chemical oxidizing ions such as iodate ions.